Graciela Pignatari

Graciela Pignatari is a dynamic Chief Scientific Officer at TISMOO, where her extensive background in molecular biology, immunology, and pharmacology uniquely positions her to lead groundbreaking initiatives in genetic research and patient care. With a Master’s degree focused on molecular biology and cancer immunology, as well as a Ph.D. concentrating on pharmacology and GPCR dimerization from UNIFESP, Graciela brings a wealth of knowledge and expertise to her role. Her academic journey, which included a pivotal sandwich doctorate at the prestigious Mount Sinai School of Medicine in New York, has equipped her with a global perspective on cutting-edge scientific advancements.

At TISMOO, Graciela plays a crucial role in coordinating the technical team, where she oversees the preparation and elaboration of genetic reports that are vital for patient diagnosis and treatment. Her commitment to fostering strong relationships with patients, parents, and multidisciplinary teams ensures that the delivery of genetic information is not only accurate but also compassionate and supportive. Graciela is also instrumental in engaging with healthcare professionals, effectively presenting TISMOO's innovative products and services to enhance understanding and collaboration in the medical community.

Her skills in immunology, research, and effective communication are complemented by her proficiency in tools such as Microsoft Office, which she utilizes to create impactful presentations and reports. Graciela's passion for science and dedication to improving patient outcomes drive her to seek new challenges and opportunities for growth in the ever-evolving field of life sciences. Her leadership at TISMOO not only reflects her commitment to scientific excellence but also her unwavering desire to make a meaningful difference in the lives of patients and their families.